FY26 Appendix 4E and Preliminary Final Report

Key points

• Revenue increased by 1.8% to $3,680,544,000
• Gross margin improved by 7.2% to $347,458,000
• Underlying EBITDA up 2.1% to $97,168,000
• Net loss of $16,028,000 due to Infinity Group provision
• Significant ECL allowance reversal of $9.3 million

Full summary

Paragon Care Ltd reported its FY26 financial results, showing a 1.8% increase in revenues to $3,680,544,000. The gross margin improved by 7.2% to $347,458,000, and underlying EBITDA increased by 2.1% to $97,168,000, driven by organic and regional growth. However, the company recorded a net loss of $16,028,000, primarily due to a provision for expected credit losses on balances due from Infinity Pharmacy Group, which amounted to $38.0 million. The Group recognized a net ECL expense of $38.0 million in profit or loss for the year, reflecting a reversal of $9.3 million against the ECL allowance recognized in the previous period.